30 research outputs found
Dirac Equation with Spin Symmetry for the Modified P\"oschl-Teller Potential in -dimensions
We present solutions of the Dirac equation with spin symmetry for vector and
scalar modified P\"oschl-Teller potential within framework of an approximation
of the centrifugal term. The relativistic energy spectrum is obtained using the
Nikiforov-Uvarov method and the two-component spinor wavefunctions are obtain
are in terms of the Jacobi polynomials. It is found that there exist only
positive-energy states for bound states under spin symmetry, and the energy
levels increase with the dimension and the potential range parameter .Comment: 9 pages and 1tabl
Effect of fluoride varnish with added casein phosphopeptide-amorphous calcium phosphate on the acid resistance of the primary enamel
Existence and blow up of solutions to a Petrovsky equation with memory and nonlinear source term
Eigensolutions of the Schrödinger equation with a class of Yukawa potentials via supersymmetric approach
Approximate solutions of the Klein–Gordon equation with unequal scalar and vector modified Hylleraas potential
Analytical solutions of the Klein–Gordon equation for Manning–Rosen potential with centrifugal term through Nikiforov–Uvarov method
Bound state solutions of the Schrödinger equation and its application to some diatomic molecules
Chlorinated plastoquinone analogs that inhibit Staphylococcus epidermidis and Candida albicans growth
ACMG clinical laboratory standards for next-generation sequencing
Next-generation sequencing technologies have been and continue to be deployed in clinical laboratories, enabling rapid transformations in genomic medicine. These technologies have reduced the cost of large-scale sequencing by several orders of magnitude, and continuous advances are being made. It is now feasible to analyze an individual's near-complete exome or genome to assist in the diagnosis of a wide array of clinical scenarios. Next-generation sequencing technologies are also facilitating further advances in therapeutic decision making and disease prediction for at-risk patients. However, with rapid advances come additional challenges involving the clinical validation and use of these constantly evolving technologies and platforms in clinical laboratories. To assist clinical laboratories with the validation of next-generation sequencing methods and platforms, the ongoing monitoring of next-generation sequencing testing to ensure quality results, and the interpretation and reporting of variants found using these technologies, the American College of Medical Genetics and Genomics has developed the following professional standards and guidelines